Scientists have found that aspirin is really effective for Oncology.
A new study conducted in Cardiff (United Kingdom), was further proof that aspirin is deservedly credited with anti-cancer properties. The authors found that aspirin significantly increases the chances of survival in people with cancer diagnoses undergoing treatment.
The staff of the school of medicine Cardiff University for five years was observed for patients treated cancer. In addition, the researchers analyzed information from archival materials, which included data on several studies of different focus groups, and 42 projects that were monitored the condition of patients with cancer of the colon, breast and prostate.
As a result, researchers from Cardiff came to the conclusion that in patients that during therapy additionally took a small dose of aspirin, decreased the proliferation and metastasis had a significant reduction in mortality. In particular, survival in these groups was increased by 15-20%.
We will note that representatives of science not the first time make the statement that aspirin can help cure cancer. So some time ago, Danish scientists concluded in their study that long-term use of aspirin in pediatric dosage can for a third reduce the risk of developing colon cancer.
Results six observations in the cases of other types of cancer also indicate a positive effect of aspirin. However, scientists do not hurry to give a clear positive response to the question of whether aspirin to treat cancer. According to them, the available data are too few to speak confidently” in this direction more research is needed.
